← Eichor
Condition: Post Ercp Pancreatitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Post Ercp Pancreatitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis
Phase 4 · 12 location(s) · Changhai Hospital · NCT07088757IV Fluids and Post-ERCP Pancreatitis
Phase N/A · 1 location(s) · University of Calgary · NCT05211206An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreati
Phase N/A · 1 location(s) · Radboud University Medical Center · NCT05267379A COMBINATION OF RECTAL INDOMETHACIN AND COLD WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACI
Phase N/A · 1 location(s) · Asian Institute of Gastroenterology, India · NCT07574970Rectal NSAIDs With/Without PD Stent for PEP Prevention
NA · 15 location(s) · Air Force Military Medical University, China · NCT07117318Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?
NA · 1 location(s) · Helsinki University Central Hospital · NCT04408482Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatograp
Phase 3 · 1 location(s) · Tanta University · NCT06861010Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS)
Phase N/A · 1 location(s) · Branislav Kuncak · NCT07244432Comparative Effectiveness Between Indomethacin and Pancreatic Stenting in the Prevention of Post ERCP Pancreatitis
Phase 3 · 7 location(s) · Chinese University of Hong Kong · NCT03713879Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitan
NA · 1 location(s) · Qilu Hospital of Shandong University · NCT07495111Early Pancreatic Stent Placement for Preventing PEP
NA · 2 location(s) · The First Affiliated Hospital of Anhui Medical University · NCT06250803Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
Phase 3 · 5 location(s) · Johns Hopkins University · NCT05252754Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis
Phase 4 · 1 location(s) · University of Calgary · NCT06260878Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatograph
Phase 3 · 1 location(s) · Tanta University · NCT06860984Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis
Phase 4 · 1 location(s) · National Cheng-Kung University Hospital · NCT07083063Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatogr
NA · 1 location(s) · GCS Ramsay Santé pour l'Enseignement et la Recherche · NCT05667987Indomethacin vs Diclofenac for Preventing PEP
NA · 20 location(s) · Air Force Military Medical University, China · NCT07071441Cold Water Irrigation Therapy as an Adjunct to Indomethacin for Post-Endoscopic Retrograde Cholangiopancreatography(ERCP
NA · 1 location(s) · University of Kansas Medical Center · NCT07330284
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.